Compare TTGT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTGT | LXRX |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.8M | 996.7M |
| IPO Year | 2024 | 2000 |
| Metric | TTGT | LXRX |
|---|---|---|
| Price | $3.84 | $2.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $10.75 | $4.15 |
| AVG Volume (30 Days) | 221.4K | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | $4.45 | N/A |
| Revenue Next Year | $2.75 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $3.37 | $1.06 |
| 52 Week High | $7.15 | $2.68 |
| Indicator | TTGT | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 36.00 |
| Support Level | $3.65 | $1.50 |
| Resistance Level | $4.11 | $2.49 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 50.00 | 26.95 |
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.